Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

SELL
$2.88 - $4.23 $95,941 - $140,913
-33,313 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$4.05 - $8.11 $56,837 - $113,815
14,034 Added 72.79%
33,313 $140,000
Q3 2021

Nov 15, 2021

SELL
$7.0 - $9.71 $392,525 - $544,488
-56,075 Reduced 74.42%
19,279 $157,000
Q2 2021

Aug 16, 2021

SELL
$7.55 - $9.42 $377,213 - $470,642
-49,962 Reduced 39.87%
75,354 $569,000
Q1 2021

May 17, 2021

BUY
$8.23 - $11.48 $398,208 - $555,459
48,385 Added 62.89%
125,316 $1.09 Million
Q4 2020

Feb 16, 2021

SELL
$7.65 - $8.98 $402,596 - $472,590
-52,627 Reduced 40.62%
76,931 $613,000
Q3 2020

Nov 16, 2020

BUY
$7.37 - $11.54 $401,952 - $629,380
54,539 Added 72.7%
129,558 $1.03 Million
Q2 2020

Aug 14, 2020

BUY
$6.28 - $10.59 $471,119 - $794,451
75,019 New
75,019 $743,000
Q1 2020

May 15, 2020

SELL
$3.77 - $7.73 $409,772 - $840,196
-108,693 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$3.61 - $5.22 $392,381 - $567,377
108,693 New
108,693 $418,000
Q3 2019

Nov 14, 2019

SELL
$4.33 - $7.63 $78,511 - $138,347
-18,132 Closed
0 $0
Q2 2019

Aug 14, 2019

SELL
$5.92 - $7.78 $194,708 - $255,884
-32,890 Reduced 64.46%
18,132 $120,000
Q1 2019

May 15, 2019

BUY
$6.82 - $8.56 $119,193 - $149,603
17,477 Added 52.1%
51,022 $386,000
Q4 2018

Feb 14, 2019

BUY
$7.05 - $12.64 $139,893 - $250,815
19,843 Added 144.82%
33,545 $271,000
Q3 2018

Nov 14, 2018

BUY
$10.95 - $14.8 $150,036 - $202,789
13,702 New
13,702 $177,000
Q2 2018

Aug 14, 2018

SELL
$6.9 - $12.35 $652,829 - $1.17 Million
-94,613 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$6.55 - $8.2 $619,715 - $775,826
94,613 New
94,613 $667,000

Others Institutions Holding CTSO

About Cytosorbents Corp


  • Ticker CTSO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 43,577,400
  • Market Cap $51.9M
  • Description
  • Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...
More about CTSO
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.